FSLY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fastly, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
June 01, 2024 08:15 ET
|
Robbins Geller Rudman & Dowd LLP
SAN DIEGO, June 01, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fastly, Inc. (NYSE: FSLY) securities between February 15, 2024 and May 1,...
Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
June 01, 2024 08:15 ET
|
Y-mAbs Therapeutics, Inc.
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and...
Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
June 01, 2024 08:05 ET
|
Y-mAbs Therapeutics, Inc.
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and...
Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
June 01, 2024 08:00 ET
|
Kymera Therapeutics, Inc.
KT-253 demonstrates initial clinical proof of concept in patients with tumor types shown to be sensitive in preclinical models, including responses in MCC and AML Evidence of target engagement...
Kaskela Law LLC Announces Shareholder Investigation of WideOpenWest, Inc. (NYSE: WOW) and Encourages Investors to Contact the Firm
June 01, 2024 08:00 ET
|
Kaskela Law
PHILADELPHIA, June 01, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating WideOpenWest, Inc. (NYSE: WOW) on behalf of the company’s shareholders. WideOpenWest shareholders...
ENPH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
June 01, 2024 07:55 ET
|
Robbins Geller Rudman & Dowd LLP
SAN DIEGO, June 01, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Enphase class action lawsuit, captioned Bialic v. Enphase Energy, Inc., No....
Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib
June 01, 2024 07:00 ET
|
Cullinan Therapeutics, Inc.
CAMBRIDGE, Mass., June 01, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today...
Aduro Clean Technologies kündigt Privatplatzierung von bis zu 2,5 Mio. USD an
June 01, 2024 05:56 ET
|
Aduro Clean Technologies Inc.
NICHT ZUR VERTEILUNG AN NACHRICHTENAGENTUREN DER VEREINIGTEN STAATEN ODER ZUR VERBREITUNG IN DEN VEREINIGTEN STAATEN LONDON, Ontario, June 01, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies...
Aduro Clean Technologies annonce un placement privé d’un montant maximal de 2,5 millions de dollars
June 01, 2024 05:56 ET
|
Aduro Clean Technologies Inc.
NE PAS DISTRIBUER AUX AGENCES DE PRESSE DES ÉTATS-UNIS ET NE PAS DIFFUSER AUX ÉTATS-UNIS LONDON, Province de l’Ontario, 01 juin 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc.. (« Aduro » ou...
VENTYX SHAREHOLDER REMINDER: BFA Law Reminds Ventyx Biosciences, Inc. (NASDAQ: VTYX) Shareholders to Contact the Firm About Ongoing Investigation
June 01, 2024 05:42 ET
|
Bleichmar Fonti & Auld
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- If you are a shareholder of Ventyx Biosciences (NASDAQ: VTYX), you are encouraged to obtain additional information by visiting...